{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:01:50Z","timestamp":1791248510626,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,12]],"date-time":"2016-02-12T00:00:00Z","timestamp":1455235200000},"content-version":"vor","delay-in-days":407,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030_152639\/1"],"award-info":[{"award-number":["310030_152639\/1"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["310030_140736"],"award-info":[{"award-number":["310030_140736"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006387","name":"Leenaards Foundation","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100006387","id-type":"DOI","asserted-by":"crossref"}]},{"name":"\u201cGustave and Simone Pr\u00e9vot\u201d"},{"name":"University of Genoa (Italy)"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vascular Pharmacology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/j.vph.2014.11.007","type":"journal-article","created":{"date-parts":[[2014,12,19]],"date-time":"2014-12-19T20:59:52Z","timestamp":1419022792000},"page":"16-27","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"special_numbering":"C","title":["Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways"],"prefix":"10.1016","volume":"64","author":[{"given":"Federico","family":"Carbone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Vuilleumier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Bertolotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Burger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Galan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Roversi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Tamborino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Casetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silva","family":"Seraceni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Trentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Dallegri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Analina Raquel","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Pende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan","family":"Artom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Mach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Coen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Fainardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Montecucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vph.2014.11.007_bb0005","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1146\/annurev-immunol-020711-074942","article-title":"Neutrophil function: from mechanisms to disease","volume":"30","author":"Amulic","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.vph.2014.11.007_bb0010","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.it.2007.06.002","article-title":"Neutrophil granules: a library of innate immunity proteins","volume":"28","author":"Borregaard","year":"2007","journal-title":"Trends Immunol"},{"key":"10.1016\/j.vph.2014.11.007_bb0015","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1093\/rheumatology\/keq045","article-title":"Neutrophil function in inflammation and inflammatory diseases","volume":"49","author":"Wright","year":"2010","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.vph.2014.11.007_bb0020","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1161\/STROKEAHA.110.578369","article-title":"Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke","volume":"41","author":"Montecucco","year":"2010","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2014.11.007_bb0025","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1160\/TH13-03-0211","article-title":"Pathophysiological role of neutrophils in acute myocardial infarction","volume":"110","author":"Carbone","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.vph.2014.11.007_bb0030","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1161\/01.STR.0000125861.55804.f2","article-title":"Matrix metalloproteinase-9 and myeloperoxidase expression: quantitative analysis by antigen immunohistochemistry in a model of transient focal cerebral ischemia","volume":"35","author":"Maier","year":"2004","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2014.11.007_bb0035","doi-asserted-by":"crossref","first-page":"H558","DOI":"10.1152\/ajpheart.01275.2004","article-title":"Leukocyte-derived matrix metalloproteinase-9 mediates blood\u2013brain barrier breakdown and is proinflammatory after transient focal cerebral ischemia","volume":"289","author":"Gidday","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.vph.2014.11.007_bb0040","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/sj.jcbfm.9600324","article-title":"Inflammatory cell infiltration after endothelin-1-induced cerebral ischemia: histochemical and myeloperoxidase correlation with temporal changes in brain injury","volume":"27","author":"Weston","year":"2007","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.vph.2014.11.007_bb0045","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1002\/jnr.21198","article-title":"Antibodies to CD11b, CD68, and lectin label neutrophils rather than microglia in traumatic and ischemic brain lesions","volume":"85","author":"Matsumoto","year":"2007","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.vph.2014.11.007_bb0050","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.nbd.2009.04.006","article-title":"Neutrophil elastase and neurovascular injury following focal stroke and reperfusion","volume":"35","author":"Stowe","year":"2009","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.vph.2014.11.007_bb0055","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1159\/000350731","article-title":"Temporal profile of matrix metalloproteinases and their inhibitors in a human endothelial cell culture model of cerebral ischemia","volume":"35","author":"Reuter","year":"2013","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.vph.2014.11.007_bb0060","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.jstrokecerebrovasdis.2009.10.008","article-title":"Matrix metalloproteinase-9 as a marker for acute ischemic stroke: a systematic review","volume":"20","author":"Ramos-Fernandez","year":"2011","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"10.1016\/j.vph.2014.11.007_bb0065","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.clinbiochem.2011.12.006","article-title":"Matrix metalloproteinase 9 mRNA: an early prognostic marker for patients with acute stroke","volume":"45","author":"Graham","year":"2012","journal-title":"Clin Biochem"},{"key":"10.1016\/j.vph.2014.11.007_bb0070","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/jth.12312","article-title":"proMetalloproteinase-10 is associated with brain damage and clinical outcome in acute ischemic stroke","volume":"11","author":"Rodriguez","year":"2013","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.vph.2014.11.007_bb0075","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s10072-012-0999-8","article-title":"Peripheral blood levels of matrix metalloproteinase-9 predict lesion volume in acute stroke","volume":"34","author":"Ulrich","year":"2013","journal-title":"Neurol Sci"},{"key":"10.1016\/j.vph.2014.11.007_bb0080","first-page":"1379","article-title":"Correlation between MMP-9 and extracellular cytokine HMGB1 in prediction of human ischemic stroke outcome","volume":"2014","author":"Sapojnikova","year":"1842","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.vph.2014.11.007_bb0085","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1161\/01.STR.0000088062.86084.F2","article-title":"Profiles of matrix metalloproteinases, their inhibitors, and laminin in stroke patients: influence of different therapies","volume":"34","author":"Horstmann","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2014.11.007_bb0090","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1212\/01.wnl.0000216133.98416.b4","article-title":"Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke","volume":"66","author":"Ning","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.vph.2014.11.007_bb0095","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1189\/jlb.0907606","article-title":"Tissue plasminogen activator (t-PA) promotes neutrophil degranulation and MMP-9 release","volume":"84","author":"Cuadrado","year":"2008","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.vph.2014.11.007_bb0100","article-title":"The effect of recombinant tissue plasminogen activator on MMP-2 and MMP-9 activities in vitro","author":"Golab","year":"2014","journal-title":"Neurol Res"},{"key":"10.1016\/j.vph.2014.11.007_bb0105","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1476-5381.2009.00068.x","article-title":"Neutrophils contribute to intracerebral haemorrhages after treatment with recombinant tissue plasminogen activator following cerebral ischaemia","volume":"156","author":"Gautier","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.vph.2014.11.007_bb0110","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/1742-2094-11-96","article-title":"Impact of the neutrophil response to granulocyte colony-stimulating factor on the risk of hemorrhage when used in combination with tissue plasminogen activator during the acute phase of experimental stroke","volume":"11","author":"Gautier","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.1016\/j.vph.2014.11.007_bb0115","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(10)70313-6","article-title":"Neurological complications of acute ischaemic stroke","volume":"10","author":"Balami","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.vph.2014.11.007_bb0120","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1159\/000088982","article-title":"Intravenous thrombolysis for acute ischaemic stroke: preliminary experience with recombinant tissue plasminogen activator in the UK","volume":"20","author":"Walters","year":"2005","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.vph.2014.11.007_bb0125","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.cellsig.2004.08.002","article-title":"CCL3 (MIP-1alpha) induces in vitro migration of GM-CSF-primed human neutrophils via CCR5-dependent activation of ERK 1\/2","volume":"17","author":"Ottonello","year":"2005","journal-title":"Cell Signal"},{"key":"10.1016\/j.vph.2014.11.007_bb0130","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1160\/TH11-05-0324","article-title":"Receptor activator of NF- kappaB ligand (RANKL) increases the release of neutrophil products associated with coronary vulnerability","volume":"107","author":"Quercioli","year":"2012","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.vph.2014.11.007_bb0135","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.cellsig.2007.11.008","article-title":"Tumor necrosis factor-alpha (TNF-alpha) induces integrin CD11b\/CD18 (Mac-1) up-regulation and migration to the CC chemokine CCL3 (MIP-1alpha) on human neutrophils through defined signalling pathways","volume":"20","author":"Montecucco","year":"2008","journal-title":"Cell Signal"},{"key":"10.1016\/j.vph.2014.11.007_bb0140","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1161\/STROKEAHA.107.181486","volume":"38","author":"Adams","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2014.11.007_bb0145","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.1161\/STR.0b013e318296aeca","article-title":"An updated definition of stroke for the 21st century: a statement for healthcare professionals from the American Heart Association\/American Stroke Association","volume":"44","author":"Sacco","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2014.11.007_bb0150","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","article-title":"Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment","volume":"24","author":"Adams","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2014.11.007_bb0155","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1161\/01.STR.20.7.864","article-title":"Measurements of acute cerebral infarction: a clinical examination scale","volume":"20","author":"Brott","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2014.11.007_bb0160","doi-asserted-by":"crossref","first-page":"3110","DOI":"10.1161\/STROKEAHA.111.613208","article-title":"Outcomes in mild or rapidly improving stroke not treated with intravenous recombinant tissue-type plasminogen activator: findings from Get With The Guidelines-Stroke","volume":"42","author":"Smith","year":"2011","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2014.11.007_bb0165","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"van Swieten","year":"1988","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2014.11.007_bb0170","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0140-6736(98)08020-9","article-title":"Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators","volume":"352","author":"Hacke","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2014.11.007_bb0175","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(00)02237-6","article-title":"Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS Study Group. Alberta Stroke Programme Early CT Score","volume":"355","author":"Barber","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.vph.2014.11.007_bb0180","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.3174\/ajnr.A1000","article-title":"An acute ischemic stroke classification instrument that includes CT or MR angiography: the Boston Acute Stroke Imaging Scale","volume":"29","author":"Torres-Mozqueda","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/j.vph.2014.11.007_bb0185","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1161\/01.STR.20.7.871","article-title":"Measurements of acute cerebral infarction: lesion size by computed tomography","volume":"20","author":"Brott","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2014.11.007_bb0190","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.intimp.2013.11.010","article-title":"Reprint of Neutrophil cell surface receptors and their intracellular signal transduction pathways","volume":"17","author":"Futosi","year":"2013","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.vph.2014.11.007_bb0195","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1749-6632.2010.05734.x","article-title":"Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment?","volume":"1207","author":"Morancho","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.vph.2014.11.007_bb0200","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1161\/01.STR.0000223001.06264.af","article-title":"Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke","volume":"37","author":"Rosell","year":"2006","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2014.11.007_bb0205","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1161\/01.CIR.0000046451.38849.90","article-title":"Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke","volume":"107","author":"Montaner","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.vph.2014.11.007_bb0210","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1161\/STROKEAHA.113.002274","article-title":"MMP9 variation after thrombolysis is associated with hemorrhagic transformation of lesion and death","volume":"44","author":"Inzitari","year":"2013","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2014.11.007_bb0215","doi-asserted-by":"crossref","first-page":"3034","DOI":"10.1161\/01.STR.31.12.3034","article-title":"Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke","volume":"31","author":"Lapchak","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2014.11.007_bb0220","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/jcbfm.2012.198","article-title":"Treatment with Evasin-3 reduces atherosclerotic vulnerability for ischemic stroke, but not brain injury in mice","volume":"33","author":"Copin","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.vph.2014.11.007_bb0225","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/01.STR.29.2.516","article-title":"Subtractive cloning identifies tissue inhibitor of matrix metalloproteinase-1 (TIMP-1) increased gene expression following focal stroke","volume":"29","author":"Wang","year":"1998","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2014.11.007_bb0230","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.3109\/02699052.2013.804206","article-title":"Effect of focal mild hypothermia on expression of MMP-9, TIMP-1, Tau-1 and beta-APP in rats with cerebral ischaemia\/reperfusion injury","volume":"27","author":"Zhao","year":"2013","journal-title":"Brain Inj"},{"key":"10.1016\/j.vph.2014.11.007_bb0235","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1161\/01.STR.0000056944.42686.1E","article-title":"Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: a Cleveland update","volume":"34","author":"Katzan","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/j.vph.2014.11.007_bb0240","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1080\/01616412.1998.11740537","article-title":"Increase in jugular levels of polymorphonuclear neutrophil elastase in patients with acute cerebral infarction","volume":"20","author":"Iwatsuki","year":"1998","journal-title":"Neurol Res"},{"key":"10.1016\/j.vph.2014.11.007_bb0245","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/hr.2009.26","article-title":"The expression of matrix metalloproteinase-13 is increased in vessels with blood\u2013brain barrier impairment in a stroke-prone hypertensive model","volume":"32","author":"Ueno","year":"2009","journal-title":"Hypertens Res"},{"key":"10.1016\/j.vph.2014.11.007_bb0250","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S1474-4422(13)70055-3","article-title":"Factors influencing haemorrhagic transformation in ischaemic stroke","volume":"12","author":"Alvarez-Sabin","year":"2013","journal-title":"Lancet Neurol"}],"container-title":["Vascular Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189114002067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1537189114002067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T15:25:08Z","timestamp":1589469908000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1537189114002067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1]]},"references-count":50,"alternative-id":["S1537189114002067"],"URL":"https:\/\/doi.org\/10.1016\/j.vph.2014.11.007","relation":{},"ISSN":["1537-1891"],"issn-type":[{"value":"1537-1891","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways","name":"articletitle","label":"Article Title"},{"value":"Vascular Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vph.2014.11.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}